All I see is a lot of extra expenses $555mil for CAPEX and $86.3mil p/yr for OPEX and the board are rewarding themselves with lots of shares for spending up big.
Still no info on the income from initial spod sales starting in July so big question mark over revenue to pay for all of this spending.
Board should not be getting any extra bonuses especially a golden parachute for PC as he is leaving SYA. Useless as a doorknob on a brick wall. Can't even get financial reports right with all his degrees.
Give us shareholders some revenue news and maybe Macq won't continue to downgrade our price target.
I'm not a down ramper as I have a lot of shares. Just upset at the constant missed targets and tipping of scale to the expense side for SYA.
- Forums
- ASX - By Stock
- SYA
- Ann: NAL Lithium Carbonate Plant Study Produces an NPV of A$3.2B
Ann: NAL Lithium Carbonate Plant Study Produces an NPV of A$3.2B, page-56
Featured News
Add SYA (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
0.003(8.57%) |
Mkt cap ! $391.1M |
Open | High | Low | Value | Volume |
3.6¢ | 3.8¢ | 3.4¢ | $2.071M | 57.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 577371 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 6055656 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 577371 | 0.037 |
8 | 1962639 | 0.036 |
12 | 4779023 | 0.035 |
23 | 8986463 | 0.034 |
27 | 10635013 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 5730656 | 32 |
0.039 | 18058076 | 24 |
0.040 | 9072479 | 35 |
0.041 | 2733104 | 11 |
0.042 | 4853856 | 12 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
SYA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online